Educación, eventos y expertos - Laboratorios centrales (2024)

Table of Contents
Cell and gene therapy answers: Addressing challenges and de-risking clinical oncology development Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore Labcorp and BML announce expansion of clinical laboratory testing capabilities in Japan Posters and publications Quantification of the monoclonal antibody pembrolizumab in human blood collected via volumetric adsorptive microsampling (VAMS) technology and utilizing LC-MS/MS detection Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists Development and validation of a fit-for-purpose biomarker LC-MS/MS assay measuring 15 plasma bile acids Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials Rational selection of Toll-like receptor agonists (TLR) for the development of Marburg vaccine formulation Second generation mRNA Marburg vaccine: Formulation development of mRNA-lipid nanoparticles with TLR9 agonist CpG oligonucleotide adjuvant A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing Conferences & events Outsourcing in Clinical Trials Southern California CASSS Mass Spec Scientific team members Aaron Ledvina, PhD Agnes Zybura, PhD Allan Watkinson, PhD Anas Tomeh, PhD Brendan Powers, PhD Caroline Heap, PhD Colin Guy, PhD Daniel Sikkema, PhD Eric Thomas, PhD Fan Jin Graeme Evans Guolan Wei Hazel Staton Heather Watson Henry Fisher, PhD James Tunaley, PhD Jennifer Courtney, PhD Jianjun Hu Jill Uhlenkamp, PhD Keith Rennier, PhD Lee Goodwin, PhD Leonard Bell, PhD Luke Bi, PhD Mark O'Dell Natalie Oldham Rachel Smith, PhD Sarah Bevington, PhD Stephanie Cape, PhD Tobey Gooding Tracy Iles Trent Kunkle Warren Rowland

Central Labs

Educación, eventos y expertos - Laboratorios centrales (1)

Article - 29 May 2024

Cell and gene therapy answers: Addressing challenges and de-risking clinical oncology development

Updates & News

Article - 13 September 2023

Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore

Press Release - 16 May 2023

Labcorp and BML announce expansion of clinical laboratory testing capabilities in Japan

Recent

Posters and publications

Poster - 2 June 2024

Quantification of the monoclonal antibody pembrolizumab in human blood collected via volumetric adsorptive microsampling (VAMS) technology and utilizing LC-MS/MS detection

Read Moreabout Quantification of the monoclonal antibody pembrolizumab in human blood collected via volumetric adsorptive microsampling (VAMS) technology and utilizing LC-MS/MS detection

Poster - 19 May 2024

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Read Moreabout Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Poster - 5 May 2024

Development and validation of a fit-for-purpose biomarker LC-MS/MS assay measuring 15 plasma bile acids

Read Moreabout Development and validation of a fit-for-purpose biomarker LC-MS/MS assay measuring 15 plasma bile acids

Poster - 4 May 2024

Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials

Read Moreabout Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials

Poster - 4 October 2023

Rational selection of Toll-like receptor agonists (TLR) for the development of Marburg vaccine formulation

Read Moreabout Rational selection of Toll-like receptor agonists (TLR) for the development of Marburg vaccine formulation

Poster - 4 October 2023

Second generation mRNA Marburg vaccine: Formulation development of mRNA-lipid nanoparticles with TLR9 agonist CpG oligonucleotide adjuvant

Read Moreabout Second generation mRNA Marburg vaccine: Formulation development of mRNA-lipid nanoparticles with TLR9 agonist CpG oligonucleotide adjuvant

Manuscript - 1 September 2020

A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing

Read Moreabout A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing

Featured

Scientific team members

Aaron Ledvina, PhD

Senior Scientific Support Specialist, LC-MS Bioanalytical Services

Read Moreabout Aaron Ledvina, PhD

Agnes Zybura, PhD

Scientist, Molecular Bioanalysis

Read Moreabout Agnes Zybura, PhD

Allan Watkinson, PhD

Director, Scientific Affairs GMP

Read Moreabout Allan Watkinson, PhD

Anas Tomeh, PhD

Research and Development Scientist

Read Moreabout Anas Tomeh, PhD

Brendan Powers, PhD

Senior Manager, LC-MS Bioanalytical Services

Read Moreabout Brendan Powers, PhD

Caroline Heap, PhD

Senior Scientist, Scientific Affairs

Read Moreabout Caroline Heap, PhD

Colin Guy, PhD

Senior Manager Assay Development, Method Development & Validation

Read Moreabout Colin Guy, PhD

Daniel Sikkema, PhD

Executive Director, Global Immunochemistry Bioanalytical Services

Read Moreabout Daniel Sikkema, PhD

Eric Thomas, PhD

Global Director of Method Development & Validation, LC-MS Bioanalytical Services

Read Moreabout Eric Thomas, PhD

Fan Jin

General Manager, Clinical Trial Testing Solutions

Read Moreabout Fan Jin

Graeme Evans

Global Director, Method Development & Validation Immunochemistry

Read Moreabout Graeme Evans

Guolan Wei

Associate Director & Site Lead, Bioanalytical Services

Read Moreabout Guolan Wei

Hazel Staton

Lead Scientist, Molecular Bioanalysis

Read Moreabout Hazel Staton

Heather Watson

Senior Manager, Lead Scientist Team, Immunochemistry

Read Moreabout Heather Watson

Henry Fisher, PhD

Assay Development Scientist, Method Development & Validation

Read Moreabout Henry Fisher, PhD

James Tunaley, PhD

Study Director & Scientist, Molecular Bioanalysis

Read Moreabout James Tunaley, PhD

Jennifer Courtney, PhD

Scientist, Molecular Bioanalysis

Read Moreabout Jennifer Courtney, PhD

Jianjun Hu

Associate Director of Bioanalysis

Read Moreabout Jianjun Hu

Jill Uhlenkamp, PhD

Senior Method Development Manager, Immunochemistry

Read Moreabout Jill Uhlenkamp, PhD

Keith Rennier, PhD

Scientist, Molecular Bioanalysis

Read Moreabout Keith Rennier, PhD

Lee Goodwin, PhD

Executive Director, Global LC-MS Bioanalytical Services

Read Moreabout Lee Goodwin, PhD

Leonard Bell, PhD

Lead Assay Development Scientist, Method Development & Validation

Read Moreabout Leonard Bell, PhD

Luke Bi, PhD

Head of Bioanalytical Services

Read Moreabout Luke Bi, PhD

Mark O'Dell

Associate Director of Global Operations, Immunochemistry

Read Moreabout Mark O'Dell

Natalie Oldham

Scientist, Molecular Bioanalysis

Read Moreabout Natalie Oldham

Rachel Smith, PhD

Assay Development Scientist, Method Development & Validation

Read Moreabout Rachel Smith, PhD

Sarah Bevington, PhD

Scientist, Molecular Bioanalysis

Read Moreabout Sarah Bevington, PhD

Stephanie Cape, PhD

Head of Research and Development and Delivery, Scientific Affairs

Read Moreabout Stephanie Cape, PhD

Tobey Gooding

Quality Control Scientist III, Quality Control

Read Moreabout Tobey Gooding

Tracy Iles

Global Head of Method Development, Molecular Bioanalysis

Read Moreabout Tracy Iles

Trent Kunkle

Scientist, Molecular Bioanalysis

Read Moreabout Trent Kunkle

Warren Rowland

Senior Quality Control Section Manager, Quality Control

Read Moreabout Warren Rowland

Educación, eventos y expertos - Laboratorios centrales (2024)
Top Articles
Latest Posts
Article information

Author: Mrs. Angelic Larkin

Last Updated:

Views: 5512

Rating: 4.7 / 5 (47 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Mrs. Angelic Larkin

Birthday: 1992-06-28

Address: Apt. 413 8275 Mueller Overpass, South Magnolia, IA 99527-6023

Phone: +6824704719725

Job: District Real-Estate Facilitator

Hobby: Letterboxing, Vacation, Poi, Homebrewing, Mountain biking, Slacklining, Cabaret

Introduction: My name is Mrs. Angelic Larkin, I am a cute, charming, funny, determined, inexpensive, joyous, cheerful person who loves writing and wants to share my knowledge and understanding with you.